ArticleJournal of oncology2022

Abrine Elicits Liver Carcinoma Immunity and Enhances Antitumor Efficacy of Immune Checkpoint Blockade by Modulating PD-L1 Signaling.

Shaowu ZhangPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.